Publication | Open Access

Relationship between immune-related adverse events and the long-term outcomes in recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab

MedicineImmunologyImmune Checkpoint InhibitorRecurrent/metastatic HeadHead And Neck CancerCancer TreatmentNeck OncologyImmunotherapyOncologyRadiation OncologyLong-term OutcomesTumor MicroenvironmentImmune-related Adverse Events